IP Library › Granted Patent US 10,138,448
Granted Patent B2
US 10,138,448 · App. 15/271,957 · Granted Nov 27, 2018

Deactivation wipe kit

Inventors: Mark J. Compo (Doylestown, PA); Michael Balestri (Mechanicsville, VA)
Assignee: VELTEK ASSOCIATES, INC
C11D17/049A61L2/18B65B5/045B65B7/02B65B51/10B65B55/08B65D31/14B65D31/145B65D75/5805B65D81/22A61L2/08A61L2202/17
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,138,448
App. No.
15/271,957
Granted
Nov 27, 2018
Kind
B2
Abstract

A hazardous drug deactivation wipe kit includes a first pouch having a one-way valve coupled to an end thereof, a second pouch, and a third pouch. The first pouch contains a wipe saturated in a hypochlorite solution, the second pouch contains a wipe saturated in thiosulfate solution, and the third pouch contains a wipe saturated in isopropyl alcohol solution. The deactivation wipe kit may be used in a clean room to deactivate most hazardous drugs on a work surface.

Claims (19)

1. A hazardous drug deactivation wipe kit, comprising:

a first pouch having a one-way filling valve coupled to an end thereof, the first pouch containing a wipe saturated in hypochlorite solution, wherein the one-way filling valve is configured to permit the hypochlorite solution to be filled into the first pouch while preventing the hypochlorite solution to escape the first pouch;

a second pouch containing a wipe saturated in thiosulfate solution; and

a third pouch containing a wipe saturated in isopropyl alcohol solution,

wherein the deactivation wipe kit is configured for use in a controlled environment to deactivate hazardous drugs on a work surface.

2. The deactivation wipe kit of claim 1 , wherein the hypochlorite solution is a 5.25% sodium hypochlorite solution.

3. The deactivation wipe kit of claim 1 , wherein the thiosulfate solution is a 2% sodium thiosulfate solution.

4. The deactivation wipe kit of claim 1 , wherein the isopropyl alcohol solution is a 70% isopropyl alcohol solution.

5. The deactivation wipe kit of claim 1 , wherein the wipe in the first pouch is formed of 100% polypropylene.

6. The deactivation wipe kit of any of claim 1 , wherein the wipe in the second pouch and the wipe in the third pouch is formed of 100% polyester.

7. The deactivation wipe kit of any of claim 1 , wherein each of the first pouch, the second pouch, and the third pouch are formed of a multi-layered structure comprised of coated polyester, low density polyethylene, aluminum foil, hydroxypropylcellulose, linear low density polyethylene, or combinations thereof.

8. The deactivation wipe kit of claim 1 , wherein each of the first pouch, the second pouch, and the third pouch comprise a perforation adjacent to an end thereof.

9. The deactivation wipe kit of any of claim 1 , wherein the one-way valve is configured to permit the first pouch to be filled with the hypochlorite solution after the wipe has already been sealed in the first pouch.

10. A deactivation wipe kit, comprising:

a first closed pouch having a one-way filling valve coupled to an end thereof, the first pouch containing a wipe saturated in first solution, wherein the one-way filling valve is configured to permit the first solution to be filled into the first pouch while preventing the first solution to escape the first pouch; and

a second closed pouch containing a wipe saturated in second solution.

11. The kit of claim 10 , further comprising a third pouch containing a wipe saturated in third solution.

12. The kit of claim 11 , wherein the first solution comprises sterile hypochlorite, the second solution comprises thiosulfate, and the third solution comprises isopropyl alcohol.

13. The kit of claim 10 , wherein the kit is configured for use in a controlled environment to deactivate hazardous drugs on a work surface.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2017
From: COMPO, MARK J.; BALESTRIC, MICHAEL
To: VELTEK ASSOCIATES, INC.
Reel/Frame 042531/0802 →
Continuity (2)
Provisional Application 62320999 · Apr 11, 2016
Related Publication 20170291054A1 · Oct 12, 2017
Cited By (4)
US 12,240,647 US 12,296,055 US 12,318,493 US 12,492,061